111 related articles for article (PubMed ID: 15261229)
21. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic variability and molecular genetics in proximal myotonic myopathy.
Papadimas GK; Kekou K; Papadopoulos C; Kararizou E; Kanavakis E; Manta P
Muscle Nerve; 2015 May; 51(5):686-91. PubMed ID: 25186227
[TBL] [Abstract][Full Text] [Related]
23. PROMM and deafness: exclusion of ZNF9 as the disease gene in DFNA18 suggests a polygenic origin of the PROMM/DM2 phenotype.
Bönsch D; Neumann C; Lang-Roth R; Witte O; Lamprecht-Dinnesen A; Deufel T
Clin Genet; 2003 Jan; 63(1):73-5. PubMed ID: 12519376
[No Abstract] [Full Text] [Related]
24. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.
Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T
PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857
[TBL] [Abstract][Full Text] [Related]
25. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
[TBL] [Abstract][Full Text] [Related]
26. Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion.
Lucchiari S; Pagliarani S; Corti S; Mancinelli E; Servida M; Fruguglietti E; Sansone V; Moggio M; Bresolin N; Comi GP; Meola G
J Neurol Sci; 2008 Dec; 275(1-2):159-63. PubMed ID: 18804219
[TBL] [Abstract][Full Text] [Related]
27. Homozygosity for CCTG mutation in myotonic dystrophy type 2.
Schoser BG; Kress W; Walter MC; Halliger-Keller B; Lochmüller H; Ricker K
Brain; 2004 Aug; 127(Pt 8):1868-77. PubMed ID: 15231584
[TBL] [Abstract][Full Text] [Related]
28. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
[TBL] [Abstract][Full Text] [Related]
29. Proximal myotonic myopathy: clinical, neuropathologic, and molecular genetic features.
Eisenschenk S; Triggs WJ; Pearl GS; Rojiani AM
Ann Clin Lab Sci; 2001 Apr; 31(2):140-6. PubMed ID: 11337902
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
[TBL] [Abstract][Full Text] [Related]
31. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
[TBL] [Abstract][Full Text] [Related]
32. Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).
Flachenecker P; Schneider C; Cursiefen S; Ricker K; Toyka KV; Reiners K
Neuromuscul Disord; 2003 May; 13(4):289-93. PubMed ID: 12868497
[TBL] [Abstract][Full Text] [Related]
33. [Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations].
Schneider C; Reiners K; Toyka KV
Nervenarzt; 2001 Aug; 72(8):618-24. PubMed ID: 11519202
[TBL] [Abstract][Full Text] [Related]
34. Proximal myotonic myopathy: a syndrome with a favourable prognosis?
Meola G; Sansone V; Marinou K; Cotelli M; Moxley RT; Thornton CA; De Ambroggi L
J Neurol Sci; 2002 Jan; 193(2):89-96. PubMed ID: 11790388
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis.
Meyer A; Lannes B; Carapito R; Bahram S; Echaniz-Laguna A; Geny B; Sibilia J; Gottenberg JE
Neuromuscul Disord; 2015 Feb; 25(2):149-52. PubMed ID: 25443993
[TBL] [Abstract][Full Text] [Related]
37. Musculoskeletal pain in patients with myotonic dystrophy type 2.
George A; Schneider-Gold C; Zier S; Reiners K; Sommer C
Arch Neurol; 2004 Dec; 61(12):1938-42. PubMed ID: 15596616
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular aspects of the myotonic dystrophies: a review.
Machuca-Tzili L; Brook D; Hilton-Jones D
Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
[TBL] [Abstract][Full Text] [Related]
39. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
40. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G
J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
